Taxotere as a cornerstone treatment of NSCLCGIACCONE, Giuseppe.Lung cancer. 2005, Vol 50, issn 0169-5002, 43 p., SUP2Conference Proceedings

Clinical potential of proteasome inhibition in solid tumoursGIACCONE, Giuseppe.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 6, pp 25-28, issn 1359-6349, 4 p.Conference Paper

Current and Future Use of Platinum Compounds in Cancer Therapy. A Seminar-in-PrintGIACCONE, Giuseppe.Drugs (Basel). 2000, Vol 59, issn 0012-6667, 43 p., SUP4Serial Issue

The potential of antiangiogenictherapy in non-small cell lung cancerGIACCONE, Giuseppe.Clinical cancer research. 2007, Vol 13, Num 7, pp 1961-1970, issn 1078-0432, 10 p.Article

Biology and management of malignant pleural mesotheliomaZUCALI, Paolo A; GIACCONE, Giuseppe.European journal of cancer (1990). 2006, Vol 42, Num 16, pp 2706-2714, issn 0959-8049, 9 p.Article

Clinical impact of novel treatment strategiesGIACCONE, Giuseppe.Oncogene (Basingstoke). 2002, Vol 21, Num 45, pp 6970-6981, issn 0950-9232, 12 p.Article

Optimizing chemotherapy for advanced non-small cell lung cancer : focus on docetaxelBELANI, Chandra P.Lung cancer. 2005, Vol 50, pp S3-S8, issn 0169-5002, SUP2Conference Paper

Adjuvant and neoadjuvant chemotherapy in NSCLC : a paradigm shiftBETTICHER, Daniel C.Lung cancer. 2005, Vol 50, pp S9-S16, issn 0169-5002, SUP2Conference Paper

Clinical perspectives on platinum resistanceGIACCONE, G.Drugs (Basel). 2000, Vol 59, pp 9-17, issn 0012-6667, SUP4Article

The role of new agents in the treatment of non-small cell lung cancerBROKER, Linda E; GIACCONE, Giuseppe.European journal of cancer (1990). 2002, Vol 38, Num 18, pp 2347-2361, issn 0959-8049, 15 p.Article

Preclinical perspectives on platinum resistanceKELLAND, L. R.Drugs (Basel). 2000, Vol 59, pp 1-8, issn 0012-6667, SUP4Article

Tyrosine Kinase Inhibitors in Lung CancerTHOMAS, Anish; RAJAN, Arun; GIACCONE, Giuseppe et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 3, issn 0889-8588, viii, 589-605 [18 p.]Article

Novel approaches to the treatment of non-small cell lung cancerFERREIRA, Carlos G; HUISMAN, Cynthia; GIACCONE, Giuseppe et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 1, pp 57-77, issn 1040-8428Article

Epidermal growth factor receptor and angiogenesis : opportunities for combined anticancer strategiesVAN CRUIJSEN, Hester; GIACCONE, Giuseppe; HOEKMAN, Klaas et al.International journal of cancer. 2005, Vol 117, Num 6, pp 883-888, issn 0020-7136, 6 p.Article

Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerRIGAS, James R; LARA, Primo N.Lung cancer. 2005, Vol 50, pp S17-S24, issn 0169-5002, SUP2Conference Paper

New developments and approaches in the platinum ArenaJUDSON, I; KELLAND, L. R.Drugs (Basel). 2000, Vol 59, pp 29-36, issn 0012-6667, SUP4Article

Optimizing chemotherapy and targeted agent combinations in NSCLCLYNCH, Thomas JR; KIM, Edward.Lung cancer. 2005, Vol 50, pp S25-S32, issn 0169-5002, SUP2Conference Paper

Drug Development: Portals of Discovery : Drug Development: What Experience Has Taught UsBATES, Susan E; AMIRI-KORDESTANI, Laleh; GIACCONE, Giuseppe et al.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 23-32, issn 1078-0432, 10 p.Article

Angiogenesis inhibitors. Drug selectivity and target specificity : Target specificity of effective anticancer therapeuticsRESISIS, Georgios; BROXTERMAN, Henk; GIACCONE, Giuseppe et al.Current pharmaceutical design. 2007, Vol 13, Num 27, pp 2795-2809, issn 1381-6128, 15 p.Article

Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignanciesLUDWIG, Heinz; KHAYAT, David; GIACCONE, Giuseppe et al.Cancer. 2005, Vol 104, Num 9, pp 1794-1807, issn 0008-543X, 14 p.Article

Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer 08975GIACCONE, Giuseppe.Seminars in oncology. 2002, Vol 29, Num 3, pp 47-49, issn 0093-7754, SUP9Article

Dacomitinib, a new therapy for the treatment of non-small cell lung cancerBRZEZNIAK, Christina; CARTER, Corey A; GIACCONE, Giuseppe et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 2, pp 247-253, issn 1465-6566, 7 p.Article

Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non-Small-Cell Lung Cancer Working Group : Standardization for Use in the Clinical Trial SettingEBERHARD, David A; GIACCONE, Giuseppe; JOHNSON, Bruce E et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 983-994, issn 0732-183X, 12 p.Article

Treatment of thymoma and thymic carcinomaGIACCONE, Giuseppe.Annals of oncology. 2000, Vol 11, pp 245-246, issn 0923-7534, SUP3Conference Paper

Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancerGIACCONE, Giuseppe.Journal of clinical oncology. 2005, Vol 23, Num 14, pp 3235-3242, issn 0732-183X, 8 p.Article